An overview of how recent funding reductions are reshaping clinical trial operations, from site sustainability and patient recruitment to trial design and long-term strategy.

After decades of recommending fewer transfusions, internist Jeffrey Carson shows why heart attack cases need more blood.

Earlier this month, in the Washington Post, Jay Bhattacharya – Professor of Medicine, health economist, and current head of ...

Oklahoma's sophomore Congresswoman met with fellow commissioners for the National Security Commission on Emerging ...

Creating clear regulatory frameworks and reimbursement standards can help ensure the responsible and effective integration of ...

A UCSF team discover how breast cancer tumors tunnel into neighboring fat cells to trigger fat breakdown in order to feed on ...

Since World War II, the U.S. has painstakingly built the world’s strongest science talent system – and with it, the most ...

The Business Research Company The Business Research Company's Asthma Disease Market Trends and Analysis by Application, Vertical, Region, a ...

Long-term use of sleep medications poses significant health risks, including increased disability, dementia, mortality, and ...

When an invasive and deadly form of breast cancer called triple-negative grows, the fat cells around it seem to shrink.UCSF ...

The global disposable endoscopes market is expected to grow at a CAGR of ~13% during the forecast period. The rising ...